Does Targeting CPP at CPPopt Actually Improve Cerebrovascular Reactivity? A Secondary Analysis of the COGiTATE...

Area of Science:

• Neuroscience
• Critical Care Medicine
• Biomedical Engineering

Background:

• The COGiTATE trial assessed feasibility and safety of targeting automated cerebral perfusion pressure (CPPopt) in traumatic brain injury (TBI) patients.
• No significant difference in mean pressure reactivity index (PRx) was found between CPPopt-targeted and standard CPP groups.
• This secondary analysis investigated PRx optimization and hourly PRx during CPPopt-guided therapy.

Purpose of the Study:

• To determine if CPPopt-guided therapy brings PRx closer to optimal PRx (PRxopt) in TBI patients.
• To assess if hourly PRx is lower when CPP is near the CPPopt target in the intervention group.
• To evaluate the impact of CPPopt targeting on cerebrovascular reactivity.

Main Methods:

• Analysis of data from 28 control and 32 intervention group patients in the COGiTATE study.
• Comparison of hourly averaged ΔPRx (PRx minus PRxopt) between groups, focusing on preserved autoregulation (negative PRxopt).
• Within the intervention group, PRx during CPP near CPPopt target (ΔCPP: -5 to +5 mm Hg) was compared to periods outside this range.

Main Results:

• Median ΔPRx was significantly lower in the intervention group for negative PRxopt (p < 0.001).
• In the intervention group, median PRx was significantly lower when CPP was close to the CPPopt target (p < 0.001).
• Results indicate improved cerebrovascular reactivity with CPPopt targeting.

Conclusions:

• Targeting CPPopt appears to improve cerebrovascular reactivity in TBI patients, despite no difference in overall mean PRx.
• This autoregulation-guided approach offers a rational intervention strategy for TBI management.
• Findings provide insights for designing future clinical protocols and trials for autoregulation-guided therapy.